Scientists at UCL have used computer-based imaging analysis to identify new patterns of lung damage in patients with Idiopathic pulmonary fibrosis (IPF), providing the first evidence of a previously unknown and life-limiting ...
Jul 16, 2021
0
7
Single-cell RNA sequencing has revealed a subset of cells that could provide protection from a rare, but severely debilitating and fatal, lung disease. The findings were published by Nagoya University researchers and colleagues ...
Jul 15, 2021
0
0
Positron emission tomography (PET) using a 68Ga-labeled fibroblast activation protein inhibitor (FAPI) can noninvasively identify and monitor pulmonary fibrosis, according to research presented at the Society of Nuclear Medicine ...
Jun 14, 2021
0
1
Doctors have hoped that antibiotics could benefit patients with chronic lung diseases, but a new study has found no benefit for patients with life-threatening idiopathic pulmonary fibrosis in preventing hospitalization or ...
Jun 2, 2021
0
6
Patients with idiopathic pulmonary fibrosis (IPF), a rare lung disease that causes shortness of breath and low oxygen levels because of lung scarring, have worse outcomes if they live in poor neighborhoods, according to research ...
May 16, 2021
0
2
The triggers and causes of a severe scarring disease of the lungs—idiopathic pulmonary fibrosis, or IPF—remain unclear.
Mar 18, 2021
0
102
Researchers at the University of Alabama at Birmingham have identified a new molecular target that could potentially treat the deadly, aging-related lung disease idiopathic pulmonary fibrosis (IPF). The study, which will ...
Mar 10, 2021
0
3
New research could shed light on the mystery cause of a lung disease that is a major killer, and potentially unlock new treatments.
Dec 8, 2020
0
10
A multi-channel recording device developed at TU Graz for pathological lung sounds and associated automatic lung sound analysis could support existing screening methods for early detection of, for example, COVID-19 infections. ...
Dec 7, 2020
0
0
A new treatment option for lung fibrosis is being developed by Purdue University scientists. Lung fibrosis has been a concern for COVID-19 patients.
Nov 11, 2020
0
3
